Episode 11 - Opioid Epidemic
In this episode, I cover the latest on Obamacare repeal (where the Republicans have pulled their repeal & replace plan), BPCIA lawsuits between Amgen ...
What The Pharma
Share:
Listens: 14
About
Answering questions around the pharmaceutical & biotechnology industry through podcast and social media
Episode 10 - Trumpcare Proposal
In this episode, I review the Trumpcare, or American Health Care Act, which is set to modify the PPACA established by Obama. After outlining the prop...
Episode 9 - Marathon pricing, Amgen v Sanofi updates, CRISPR lawsuit, and Editing baby genes
In this episode, I cover the recent issue with Marathon's pricing of a steriod drug for DMD, updates to Amgen v Sanofi and the new biosimilar lawsuit ...
Episode 8 - Trump's FDA deregulation proposal, 21st Century Cures Act, and Value-based Reimbursement Model
In this episode, I open with the latest #GOBOLDY (read: Go Boldy, not GOB OLDY) campaign by the industry trade association, PhRMA, then move onto Trum...
Episode 7 - Science, PhRMA campaign and new discoveries and J&J's R&D productivity stop gap M&A
In this episode, I discuss the new Pfizer campaign around scientists as well as Martin Shkreli's response to the Davos comments. Then we discuss J&J'...
Episode 6 - Getting away with Murder? Reputation of Pharma & Future of R&D Productivity
In this episode, I recap briefly heresay around the pharmaceutical industry from the new POTUS and a Pharma CEO then move onto updates around the repe...
Episode 5 - Amgen v Sanofi patent case and injunction and Obamacare repeal
In this very long 30+min episode, I discuss the race between Amgen and Sanofi to launch the first PCSK9 drug into the market space. Try to keep up wi...
Episode 4 - Trends in 2017: Power to Patients, Payers, Changes in Regulation and Lower R&D Productivity
In this episode, I take a look at the Magic 8 Ball to determine the trends to watch out for in Pharma for 2017. Patient consumerism continues to incr...
Episode 3 - Drug Promotions, Patient Consumerism, and Free Speech
In this special Christmas/Holiday episode, I cover the drug promotions you hear on radio and TV. Why are drugs promoted? How are they regulated? Wher...
Episode 2 - Tamiflu Generic, Biosimilars, Pricing and Policy Implications
In this episode, I discuss what it means now that Tamiflu generic has been approved and introduced in several markets. Generics and biosimilars are e...